2015 Annual Meeting | 6MS.001 - Prognostication in the Era of Hypothermia

Date Thursday 04/23/15

Time 06:30 AM - 08:00 AM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Morning Seminar

Director(s) Romergryko G. Geocadin, MD, FAAN

Topic(s)

Learning Objectives Participants should learn recent advances in the use of therapeutic hypothermia and targeted temperature management for acute brain injuries, especially after resuscitation from cardiac arrest; how these therapeutic interventions can alter the neurologic recovery and affect the previously established prognostic paradigms; and emerging prognostication modalities and their application in patients subjected to targeted temperature management. Participants should also be familiar with the potential impact of therapeutic hypothermia in the determination of death by neurologic criteria; and be made aware of ongoing research, limitations of recent studies, and existing consensus statements and practice guidelines related to prognostication and temperature management.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Interpersonal and Communication Skills, Professionalism, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Recommended Audience Trainee, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic, Audience Participation

Event Timeline
06:30 AM - 07:00 AM		Therapeutic Hypothermia and Targeted Temperature Management in Brain Injury After Cardiac Arrest Resuscitation Romergryko G. Geocadin, MD, FAAN
07:00 AM - 07:30 AM		Prognostication in Hypothermia and Non-hypothermia Treated Patients David M. Greer, MD, FAAN
07:30 AM - 07:40 AM		Therapeutic Hypothermia and Death by Neurologic Criteria David M. Greer, MD, FAAN
07:40 AM - 07:50 AM		Therapeutic Hypothermia: Ongoing Research and Future Direction Romergryko G. Geocadin, MD, FAAN
07:50 AM - 08:00 AM		Questions and Answers

Faculty Disclosures
Romergryko G. Geocadin, MD, FAAN	Dr. Geocadin has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Consulting.
David M. Greer, MD, FAAN	Dr. Greer has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Thieme, Inc. Dr. Greer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for multiple. An immediate family member of Dr. Greer has or had stock in Vertex Pharmaceuticals. The institution of Dr. Greer has received research support from NINDS. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has received publishing royalties from a publication relating to health care. Dr. Greer has a non-compensated relationship as a Treasurer-Elect with American Neurological Association that is relevant to AAN interests or activities. Dr. Greer has a non-compensated relationship as a President with Neurocritical Care Society that is relevant to AAN interests or activities.

��ɫ��

��ɫ��